Medical devices, healthcare technology and the business of care
510(k) clearance · K261649

Excelsior Reach Microcatheter

Stryker Neurovascular · Decision date Oct 9, 2026

MEDTECHLEDGER EXPLANATIONK261649

What did the FDA decide?

Stryker Neurovascular received a substantially equivalent (SESE) decision for the Excelsior Reach Microcatheter under 510(k) K261649, dated October 9, 2026. This is a clearance, not a PMA approval. The device is a single-lumen, single-use, sterile percutaneous catheter classified under 21 CFR 870.1250 (Class II), with primary product code QJP and subsequent code DQY; the FDA database lists the regulation medical specialty as Cardiovascular and the review panel as Neurology.

The submission describes a catheter offered in 155 cm and 165 cm effective lengths and straight or pre-shaped tips, with two distal radiopaque markers, a Luer hub, and a hydrophilic coating, supplied with a peel-away introducer sheath and steam-shaping accessories. The summary names the Excelsior SL-10 Pre-Shaped Microcatheter (K042568) as predicate and the Headway Duo Microcatheter (K120917) as reference. Bench testing listed in the summary is reported as passing; the record does not include clinical outcome data, and the labeled six-month shelf life is stated without supporting results detail.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 9, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261649
Regulatory pathway
510(k) premarket notification
Product code
QJP
Decision code
SESE
Decision date
Oct 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Percutaneous, Neurovasculature.

Product code
QJP
FDA device class
2

FDA decision timeline

  1. K261649 received

    Application receipt date recorded by FDA.

  2. K261649 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QJP

Product / regulatory recordCompanyPathwayDecision dateSource
Perfuze, Ltd.510(k) clearanceNov 5, 2026FDA
Alembic, LLC510(k) clearanceOct 6, 2026FDA
Cognition Medical Corp.510(k) clearanceOct 2, 2026FDA
Route 92 Medical, Inc.510(k) clearanceSep 16, 2026FDA
Piraeus Medical, Inc.510(k) clearanceSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Stryker Neurovascular

Headquarters
Not reported
Brand website
stryker.com
FDA applicant address
Fremont, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records